A new strategy to disrupt protein-protein interactions in eukaryotic cells.
A new strategy to disrupt protein-protein interactions in eukaryotic cells.
批准号:
8710286
负责人:
Hidde L. Ploegh
金额:
$97.5万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-30 至 2017-07-31
关键词:
AffinityAffinity ChromatographyAlpacaAntibodiesAntigen TargetingAntigensBacteriophagesBinding SitesBiologyBiotinCellsCellular biologyChemicalsCleaved cellComplementCytoplasmic ProteinDiseaseElementsEnzymesEukaryotaEukaryotic CellFluorescence MicroscopyGeneticImageryLaboratoriesLibrariesMHC Class II GenesMusNuclear PoreOrganismPhage DisplayPhysiologyPost-Translational Protein ProcessingProductionProteinsProteomicsRNA InterferenceReactionRetrievalRunningSiteSpecificitySplenocyteTechnologyWorkYeastsabstractingbasedisulfide bondexpression vectorfluorophoreglycosylationinterestliquid chromatography mass spectrometryprotein protein interactionsortasesynthetic biologysynthetic peptidethreonyl-glycinetoolubiquitin ligase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION
Abstract:
Vhh’s require neither disulfide bonds nor glycosylation for stability; they are remarkably thermostable as
well. By immunizing an alpaca with cytoplasmic proteins from the organism of interest, a representative set of
such Vhh’s will be generated and isolated by means of selective amplification of the Vhh sequences present by
PCR, followed by expression of the Vhh’s as a library in phage display mode. At the C-terminus of each Vhh,
the phage expression vectors carry a recognition motif for sortase, a bacterial enzyme that allows quantitative
and site-specific modification of proteins of interest, including Vhh’s. Sortases recognize an LPXTG motif, and
cleave between the Thr and Gly residues with concomitant formation of a thioacyl intermediate. Short synthetic
peptides, modified according to need with fluorophores, biotin or combinations of thereof, resolve this thioacyl
intermediate and allow covalent, near-quantitative and site-specific installation of such probes at the site of
sortase cleavage, without inflicting chemical damage on the Vhh antigen combining site. This allows the rapid
production of Vhh’s that are affinity tagged with biotin. They can be used directly for retrieval of the target
antigen to facilitate its identification by affinity purification and proteomic (LC/MS/MS) analysis. Indeed, this
unbiased approach has been successfully reduced to practice in a trial run in the applicant’s laboratory, leading
to the isolation of a high affinity Vhh that recognizes murine class II MHC products, starting from a library
constructed from an alpaca immunized with unfractionated mouse splenocytes. The next targets envisioned
are components of the yeast nuclear pore, available in mg amounts.
While some yeast work has been performed in the applicant’s laboratory, the proposed project presents
the first serious foray into yeast cell biology, but with obvious extensions into multicellular eukaryotes. A key
element to the approach is the lack of a requirement for immunochemical tools such as secondary antibodies
to rapidly identify the target antigens for which the isolated Vhh’s are specific. The ease of installation of biotin
and fluorophores, alone or in combination, by means of the sortase reaction also enables the use of any Vhh of
interest as a purification tool or a handle for visualization by cytofluorimetry or fluorescence microscopy.
Moreover, because Vhh are single domains, they can be genetically fused and expressed as fusion partners of
other proteins of interest (e.g. GFP for localization studies of the target antigen; ubiquitin ligases for selective
degradation of the target antigen; fusion to a protein of interest to bring about selective association of that
protein with the Vhh target antigen) as a step towards synthetic biology in eukaryotes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Imposing order on the family of ubiquitin-conjugating (E2) enzymes through intracellular perturbation with nanobodies
-
批准号:10464850
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2021
-
负责人:Hidde L. Ploegh
-
依托单位:
Non-invasive imaging of the anti-tumor immune response
-
批准号:10520018
-
项目类别:
-
资助金额:$57.59万
-
财政年份:2020
-
负责人:Hidde L. Ploegh
-
依托单位:
Non-invasive imaging of the anti-tumor immune response
-
批准号:10318578
-
项目类别:
-
资助金额:$57.59万
-
财政年份:2020
-
负责人:Hidde L. Ploegh
-
依托单位:
Imposing order on the family of ubiquitin-conjugating (E2) enzymes through intracellular perturbation with nanobodies
-
批准号:10461021
-
项目类别:
-
资助金额:$123.9万
-
财政年份:2019
-
负责人:Hidde L. Ploegh
-
依托单位:
Imposing order on the family of ubiquitin-conjugating (E2) enzymes through intracellular perturbation with nanobodies
-
批准号:10208670
-
项目类别:
-
资助金额:$123.9万
-
财政年份:2019
-
负责人:Hidde L. Ploegh
-
依托单位:
Imposing order on the family of ubiquitin-conjugating (E2) enzymes through intracellular perturbation with nanobodies
-
批准号:10671648
-
项目类别:
-
资助金额:$123.9万
-
财政年份:2019
-
负责人:Hidde L. Ploegh
-
依托单位:
Imposing order on the family of ubiquitin-conjugating (E2) enzymes through intracellular perturbation with nanobodies
-
批准号:10002176
-
项目类别:
-
资助金额:$123.9万
-
财政年份:2019
-
负责人:Hidde L. Ploegh
-
依托单位:
Non-invasive imaging of the immune response based on the use of isotopically labeled single domain antibody fragments
-
批准号:8873207
-
项目类别:
-
资助金额:$29.25万
-
财政年份:2015
-
负责人:Hidde L. Ploegh
-
依托单位:
Sortase-mediated installation of recognition modules on T cells for redirected ki
-
批准号:8683479
-
项目类别:
-
资助金额:$25.45万
-
财政年份:2014
-
负责人:Hidde L. Ploegh
-
依托单位:
Endosomal TLRs and their accessory proteins: cell biology and biochemistry
-
批准号:8454409
-
项目类别:
-
资助金额:$35.75万
-
财政年份:2012
-
负责人:Hidde L. Ploegh
-
依托单位:
Enzymatic modification of anti-DEC205 to manipulate its immunogenic properties
-
批准号:8386128
-
项目类别:
-
资助金额:$29.25万
-
财政年份:2012
-
负责人:Hidde L. Ploegh
-
依托单位:
A new strategy to disrupt protein-protein interactions in eukaryotic cells.
-
批准号:8550122
-
项目类别:
-
资助金额:$94.58万
-
财政年份:2012
-
负责人:Hidde L. Ploegh
-
依托单位:
A new strategy to disrupt protein-protein interactions in eukaryotic cells.
-
批准号:9381676
-
项目类别:
-
资助金额:$59.3万
-
财政年份:2012
-
负责人:Hidde L. Ploegh
-
依托单位:
A new strategy to disrupt protein-protein interactions in eukaryotic cells.
-
批准号:8351788
-
项目类别:
-
资助金额:$97.5万
-
财政年份:2012
-
负责人:Hidde L. Ploegh
-
依托单位:
Enzymatic modification of anti-DEC205 to manipulate its immunogenic properties
-
批准号:8518230
-
项目类别:
-
资助金额:$22.91万
-
财政年份:2012
-
负责人:Hidde L. Ploegh
-
依托单位:
A new strategy to disrupt protein-protein interactions in eukaryotic cells.
-
批准号:8900317
-
项目类别:
-
资助金额:$97.5万
-
财政年份:2012
-
负责人:Hidde L. Ploegh
-
依托单位:
Endosomal TLRs and their accessory proteins: cell biology and biochemistry
-
批准号:8250504
-
项目类别:
-
资助金额:$37.05万
-
财政年份:2012
-
负责人:Hidde L. Ploegh
-
依托单位:
A new strategy to disrupt protein-protein interactions in eukaryotic cells.
-
批准号:9117623
-
项目类别:
-
资助金额:$32.18万
-
财政年份:2012
-
负责人:Hidde L. Ploegh
-
依托单位:
UBIQUITIN C-TERMINAL HYDROLASE L3 COMPLEX WITH UBIQUITIN-BASED SUICIDE SUBSTRATE
-
批准号:8361612
-
项目类别:
-
资助金额:$0.33万
-
财政年份:2011
-
负责人:Hidde L. Ploegh
-
依托单位:
Sortase-mediated protein engineering for the study of host-pathogen interactions
-
批准号:8431398
-
项目类别:
-
资助金额:$45.37万
-
财政年份:2010
-
负责人:Hidde L. Ploegh
-
依托单位:
海外基金